Houston, TX, United States of America

Ana Beatriz Korngold

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ana Beatriz Korngold. Retrieved from https://idiyas.com/inventor/ana-beatriz-korngold

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ana Beatriz Korngold: Innovator in Chimeric Antigen Receptors

Introduction

Ana Beatriz Korngold is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CAR). With a total of 2 patents, her work is paving the way for advancements in cancer treatment and immunotherapy.

Latest Patents

Ana Beatriz Korngold's latest patents focus on the methods of generating chimeric antigen receptors. These patents provide innovative methods for library screening of CAR by generating a vector encoding the CAR from random attachment of vectors from libraries of vectors encoding antigen-binding domains, hinge regions, and endodomains. In some embodiments, the vectors contain a transposon, enhancing the efficiency of CAR development.

Career Highlights

Ana is affiliated with the University of Texas System, where she continues to push the boundaries of research in her field. Her work has garnered attention for its potential applications in treating various forms of cancer, showcasing her dedication to improving patient outcomes through innovative technology.

Collaborations

Ana collaborates with notable colleagues, including Simon Olivares and Harjeet Singh. These partnerships enhance her research efforts and contribute to the advancement of knowledge in the field of immunotherapy.

Conclusion

Ana Beatriz Korngold is a trailblazer in the development of chimeric antigen receptors, with her innovative patents and collaborative efforts marking her as a key figure in biotechnology. Her contributions are vital to the future of cancer treatment and immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…